DK2877494T3 - PTPRS og proteoglycaner i autoimmun sygdom - Google Patents
PTPRS og proteoglycaner i autoimmun sygdom Download PDFInfo
- Publication number
- DK2877494T3 DK2877494T3 DK13823022.2T DK13823022T DK2877494T3 DK 2877494 T3 DK2877494 T3 DK 2877494T3 DK 13823022 T DK13823022 T DK 13823022T DK 2877494 T3 DK2877494 T3 DK 2877494T3
- Authority
- DK
- Denmark
- Prior art keywords
- ptprs
- proteoglycans
- autoimmune disease
- autoimmune
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261674853P | 2012-07-23 | 2012-07-23 | |
US201261675036P | 2012-07-24 | 2012-07-24 | |
US201361832688P | 2013-06-07 | 2013-06-07 | |
PCT/US2013/051723 WO2014018554A1 (en) | 2012-07-23 | 2013-07-23 | Ptprs and proteoglycans in autoimmune disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2877494T3 true DK2877494T3 (da) | 2020-09-21 |
Family
ID=49997782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13823022.2T DK2877494T3 (da) | 2012-07-23 | 2013-07-23 | PTPRS og proteoglycaner i autoimmun sygdom |
Country Status (5)
Country | Link |
---|---|
US (2) | US20150175979A1 (da) |
EP (1) | EP2877494B1 (da) |
DK (1) | DK2877494T3 (da) |
ES (1) | ES2817897T3 (da) |
WO (1) | WO2014018554A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
CA3063061A1 (en) * | 2016-05-12 | 2017-11-16 | Ohio State Innovation Foundation | Peptides and methods for treating neurodegenerative disorders |
JP2020514394A (ja) * | 2017-03-24 | 2020-05-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 異常な線維芽細胞におけるプロテオグリカンの不規則性及びそれに基づく治療法 |
WO2020061381A1 (en) | 2018-09-19 | 2020-03-26 | La Jolla Institute For Immunology | Ptprs and proteoglycans in rheumatoid arthritis |
CA3225321A1 (en) * | 2021-07-30 | 2023-02-02 | Nunzio Bottini | Ptprs in autoimmunity |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
EP0247091B1 (en) | 1985-11-01 | 1993-09-29 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
CA2062795A1 (en) | 1989-06-29 | 1990-12-30 | Michael W. Fanger | Bispecific reagents for aids therapy |
US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
DE69133476T2 (de) | 1990-08-29 | 2006-01-05 | GenPharm International, Inc., Palo Alto | Transgene Mäuse fähig zur Produktion heterologer Antikörper |
WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
US5777085A (en) | 1991-12-20 | 1998-07-07 | Protein Design Labs, Inc. | Humanized antibodies reactive with GPIIB/IIIA |
US6210671B1 (en) | 1992-12-01 | 2001-04-03 | Protein Design Labs, Inc. | Humanized antibodies reactive with L-selectin |
US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
TW589189B (en) | 1997-08-04 | 2004-06-01 | Scras | Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
GB9827152D0 (en) | 1998-07-03 | 1999-02-03 | Devgen Nv | Characterisation of gene function using double stranded rna inhibition |
ATE477273T1 (de) | 1998-12-01 | 2010-08-15 | Facet Biotech Corp | Humanisierte antikoerper gegen gamma-interferon |
EP1147204A1 (en) | 1999-01-28 | 2001-10-24 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
JP2003516124A (ja) | 1999-10-15 | 2003-05-13 | ユニバーシティー オブ マサチューセッツ | 標的とした遺伝的干渉の手段としてのrna干渉経路遺伝子 |
GB9927444D0 (en) | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
JP2004532616A (ja) | 2000-12-28 | 2004-10-28 | ジョンソン・アンド・ジョンソン・リサーチ・ピー・ティー・ワイ・リミテッド | 二本鎖rna仲介遺伝子抑制 |
JP2009510102A (ja) * | 2005-09-29 | 2009-03-12 | ヴァイラル ロジック システムズ テクノロジー コーポレーション | 免疫調節組成物およびその使用 |
EP2531859A4 (en) * | 2010-02-02 | 2013-07-31 | Jolla Inst Allergy Immunolog | COMPOSITIONS AND METHOD FOR MODULATING RECEPTOR PROTEIN TYROSINE PHOSPHATASES |
PL2702412T3 (pl) * | 2011-04-28 | 2018-01-31 | Sbi Biotech Co Ltd | Przeciwciało przeciwko ludzkiej białkowej fosfatazie tyrozynowej typu receptorowego |
-
2013
- 2013-07-23 DK DK13823022.2T patent/DK2877494T3/da active
- 2013-07-23 ES ES13823022T patent/ES2817897T3/es active Active
- 2013-07-23 WO PCT/US2013/051723 patent/WO2014018554A1/en active Application Filing
- 2013-07-23 US US14/416,839 patent/US20150175979A1/en active Pending
- 2013-07-23 EP EP13823022.2A patent/EP2877494B1/en active Active
-
2022
- 2022-06-23 US US17/848,241 patent/US20220325261A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2014018554A1 (en) | 2014-01-30 |
US20150175979A1 (en) | 2015-06-25 |
EP2877494A4 (en) | 2016-04-20 |
ES2817897T3 (es) | 2021-04-08 |
US20220325261A1 (en) | 2022-10-13 |
EP2877494B1 (en) | 2020-07-15 |
EP2877494A1 (en) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
DK2839860T3 (da) | Pyrrolobenzodiazepiner og konjugater deraf | |
DK3470086T3 (da) | Pyrrolobenzodiazepiner og konjugater deraf | |
DK2844282T3 (da) | Prostata-associerede antigener og vaccine-baserede immunterapiregimener | |
DK2838596T3 (da) | Intermitterende katetersamling | |
HK1206667A1 (en) | Extracellular matrix encasement structures and methods | |
DK2815483T3 (da) | Flerrumsatterioplader | |
BR302012004119S1 (pt) | Configuração aplicada em unidade de carga | |
BR302013000588S1 (pt) | Configuração aplicada em instrumento médico | |
BR112014000049A2 (pt) | pirrolotriazinas substituídas com hidroximelilarilo e sua utilização | |
BR112012029414A2 (pt) | arquiteturas ordenadas em polímeros acrílicos | |
DK3453723T3 (da) | Anti-ASIC1-antistoffer og anvendelser deraf | |
DK3326642T3 (da) | Langtidsvirkende koagulationsfaktorer og brugen deraf | |
BR302013001848S1 (pt) | Configuração aplicada em instrumento médico | |
DK2877494T3 (da) | PTPRS og proteoglycaner i autoimmun sygdom | |
BR302013000213S1 (pt) | Configuração aplicada em instrumento médico | |
BR302012006078S1 (pt) | Configuração aplicada em instrumento médico | |
FR3015775B1 (fr) | Butee de cosse de batterie et unite de cosse de batterie | |
DK2441354T3 (da) | Hyldeenhed og hyldesystem | |
EP2777789A4 (en) | ELEMENT OF A BUILDING GAME (AND VARIANTS) AND BUILDING GAME | |
GB2511282B (en) | Improvements in or relating to hinge arrangements | |
BR112013013208A2 (pt) | bogie e sua estrutura lateral | |
DK2812435T3 (da) | Transskriptionsenheder og anvendelse heraf i ekspressionsvektorer | |
BR302013000215S1 (pt) | Configuração aplicada em instrumento médico | |
BR302012006531S1 (pt) | Configuração aplicada em pingadeira |